Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds BIOIX.
No tracked institution reports a position in BIOIX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-16 | $2.2870 | 2025-12-17 |
| 2024-12-17 | $2.3307 | 2024-12-18 |
No one on the platform has traded BIOIX yet.
| $33.44 |
| +1.18% |
| $1.9B |
| — |
| HFCIXHennessy Focus Fund Institutional Class | $42.88 | +4.71% | $1.3B | — |
| PCCOXT. Rowe Price U.S. Equity Research Fund I Class | $74.12 | +1.30% | $1.9B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.